Toxicological Sciences, Vol 48, 82-89, Copyright © 1999 by Society of Toxicology
S Zhou and KB Wallace
Peroxisome proliferators are a group of structurally diverse chemicals that
cause the proliferation of peroxisomes in rodents. The purpose of this
investigation was to test the hypothesis that the shared effect of these
compounds on peroxisome proliferation is mediated through a common
inhibitory effect on mitochondrial bioenergetics. Freshly isolated rat
liver mitochondria were energized with succinate. The effect of the
chemicals on mitochondrial bioenergetics was analyzed by monitoring
calcium-induced changes in membrane potential and swelling, as well as
changes in mitochondrial respiration. Mitochondrial membrane potential was
measured with a TPP(+)-sensitive electrode, and swelling was recorded
spectrophotometrically. Mitochondrial oxygen uptake was monitored with a
Clark-type oxygen electrode. Gemfibrozil and WY-14,643 induced the
mitochondrial permeability transition as characterized by calcium-induced
swelling and depolarization of membrane potential, both of which were
inhibited by cyclosporine A. Fenofibrate, clofibrate, ciprofibrate and
diethylhexyl phthalate, on the other hand, caused a direct dose-dependent
depolarization of mitochondrial membrane potential. However, the mechanism
of membrane depolarization varied among the test chemicals. Bezafibrate and
trichloroethylene elicited no effect on succinate-supported mitochondrial
bioenergetics. The results of this investigation demonstrate that although
most, but not all, peroxisome proliferators interfere with mitochondrial
bioenergetics, the specific biomolecular mechanism differs among the
individual compounds.
ARTICLES
The effect of peroxisome proliferators on mitochondrial bioenergetics
Department of Biochemistry and Molecular Biology, University of Minnesota School of Medicine, Duluth 55812, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Constantin, D. Constantin-Teodosiu, R. Layfield, K. Tsintzas, A. J. Bennett, and P. L. Greenhaff PPAR{delta} agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle J. Physiol., August 15, 2007; 583(1): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, R. A. Jolly, B. W. Halstead, T. K. Baker, J. P. Stutz, M. Huffman, J. N. Calley, A. West, H. Gao, G. H. Searfoss, et al. Underlying Mechanisms of Pharmacology and Toxicity of a Novel PPAR Agonist Revealed Using Rodent and Canine Hepatocytes Toxicol. Sci., April 1, 2007; 96(2): 294 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hynes, L. D. Marroquin, V. I. Ogurtsov, K. N. Christiansen, G. J. Stevens, D. B. Papkovsky, and Y. Will Investigation of Drug-Induced Mitochondrial Toxicity Using Fluorescence-Based Oxygen-Sensitive Probes Toxicol. Sci., July 1, 2006; 92(1): 186 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Peraza, A. D. Burdick, H. E. Marin, F. J. Gonzalez, and J. M. Peters The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR) Toxicol. Sci., April 1, 2006; 90(2): 269 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. O'Brien and K. B. Wallace Mitochondrial Permeability Transition as the Critical Target of N-Acetyl Perfluorooctane Sulfonamide Toxicity in Vitro Toxicol. Sci., November 1, 2004; 82(1): 333 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brunmair, A. Lest, K. Staniek, F. Gras, N. Scharf, M. Roden, H. Nohl, W. Waldhausl, and C. Furnsinn Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Starkov and K. B. Wallace Structural Determinants of Fluorochemical-Induced Mitochondrial Dysfunction Toxicol. Sci., April 1, 2002; 66(2): 244 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Szewczyk and L. Wojtczak Mitochondria as a Pharmacological Target Pharmacol. Rev., March 1, 2002; 54(1): 101 - 127. [Abstract] [Full Text] [PDF] |
||||



